Education and Experience
- Cornell University Medical College (Ithaca NY)/ (1985)
- Johns Hopkins University School of Medicine (Baltimore MD)/ Internal Medicine (1988)
- Johns Hopkins University School of Medicine (Baltimore MD)/ Cardiology (1992)
- Cardiovascular Disease, American Board of Internal Medicine (2003)
- Internal Medicine, American Board of Internal Medicine (1988)
Medicine - Cardiology
- Ciccarone Center for Preventive Cardiology
- Heart and Vascular Institute
Dr. Blumenthal was the principal developer of the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, and he is the Director of Preventive Cardiology at Johns Hopkins. He is a member of the official national spokesperson panel for the American Heart Association (A.H.A.).
An experienced writer, Dr. Blumenthal is on the editorial board of The American Heart Journal, Clinical Cardiology and the American College of Cardiology Extended Learning Center (ACCEL). He is the Preventive Cardiology/Coronary Heart Disease section editor of Cardiology Today. He is editor of the annual Johns Hopkins White Paper on Prevention of Heart Disease.
Named One of Baltimore Magazine's Top Cardiologist (2010, 2012)
President of American Heart Association, Greater Baltimore Chapter (2012)
Named one of US News and World Reports Top Doctors (2011)
Recipient of the David Levine Mentorship Award in Johns Hopkins Department of Medicine (2010)
Selected as One of the Top Cardiologist in American by Men's Health Magzine (2007, 2008)
Chairman, American College of Cardiology Committee for Prevention of Cardiovascular Disease (2005-2009)
Past President, American Heart Association, Maryland Council (2001)
Member of American Heart Association, National Spokespersons Panels.
Recipient of American Heart Association Maryland Affiliate Presidential Recognition Award and the Unsung Hero Award.
- Cardiovascular Computed Tomography
- Cardiovascular Disease
- Cardiovascular Disease in Women
- Cardiovascular Risk Stratification
- Chest pain
- Clinical Cardiology
- Coronary Artery Disease
- Coronary CT Angiography
- Dyslipidemia and Hypertension
- General Cardiology
- Heart Disease
- Heart Disease Prevention and Treatment in Women
- High Cholesterol
- Ischemic Heart Disease
- Preventive Cardiology
- Stress Testing
Past Chair of Hypertension, Vascular, and Prevention Section of the 2006 American College of Cardiology Scientific Sessions
Medical Director, 2002 U.S. Senior Open
Past President, American Heart Association Maryland Affiliate
Current Member, American Heart Association Expert Panel on Subclinical Atherosclerotic Disease and Emerging Risk Factors.
Chairman, American College of Cardiology Foundation COCATS Update for Training in Preventive Cardiovascular Medicine.
Past member of NHLBI Working Working on the Integrative Approach to Identify Patients at High Risk of a Cardiovascular Event in the Near Future.
2. Mora S, Redberg RF, Sharrett AR, Blumenthal RS. Enhanced Risk Assessment in Asymptomatic Individuals Using Exercise Testing and Framingham Risk Scores. Circulation. 2005;112:1566-72.
3. Michos ED, Nasir K, Braunstein JB, Rumberger JA, Budoff MJ, Post WS, Blumenthal RS. Framingham Risk Equation Underestimates Subclinical Atherosclerosis Risk in Asymptomatic Women. Atherosclerosis. 2006; 184:201-206.
4. Nasir K, Budoff MJ, Wong ND, Scheuner M, Herrington D, Arnett DK, Szklo M, Greenland P, Blumenthal RS. Family History of Premature Coronary Heart Disease and Coronary Artery Calcification: Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2007;116:619-26.
5. Blumenthal RS, Michos ED, Nasir K. Further Improvements in CHD Risk Prediction for Women. JAMA. 2007; 297:641-3.
6. Lakoski SG, Greenland PG, Wong ND, Schreiner PJ, Herrington DM, Kronmal RA, Liu K, Blumenthal RS.
Coronary Artery Calcium Scores and Risk for Cardiovascular Events in Women Classified as Low Risk Based on Framingham Risk Score: The Multi-Ethnic Study of Atherosclerosis. Arch Intern Med. 2007;167:2437-2442.
7. Michos ED, Blumenthal RS. Prevalence of Low Low-Density Lipoprotein Cholesterol with Elevated High-Sensitivity C-reactive Protein in the U.S.- Implications of the JUPITER Study. J Am Coll Cardiol. 2009; 53:931-5.
8. Blumenthal RS, Michos ED. The HALTS Trial Halting Atherosclerosis or Halted Too Early? N Engl J Med. 2009; 361:2178-90.
9. Budoff MJ, McClelland RL, Nasir K, Greenland P, Kronmal RA, Kondos GT, Shea S, Limia JAC, Blumenthal RS. Cardiovascular Events with Absent or Minimal Coronary Calcification: The Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J. 2009; 158:554-61.
10. Weiss SA, Blumenthal RS, Sharrett AR, Redberg RF, Mora S. Exercise Blood Pressure and Future Cardiovascular Death in Asymptomatic Individuals. Circulation. 2010; 121: 2109-16.
11. Berger JS, Jordan CO, Lloyd-Jones D, Blumenthal RS. Screening for Cardiovascular Risk in Asymptomatic Patients. J Am Coll Cardiol. 2010; 55:1169-72.
12. Silverman MG, Blaha MJ, Blumenthal RS. Adjunctive Lipid Lowering Therapy in the Era of Surrogate Endpoints. Cardiol Rev. 2011;17-22.
13. Blankstein R, Budoff MJ, Shaw LJ, Goff DC, Polak JF, Lima J, Blumenthal RS, Nasir K. Predictors of Coronary Heart Disease Events Among Asymptomatic Individuals with Low LDL Cholesterol; MESA. J Am Coll Cardiol. 2011; 58:364-74.
14. Blaha MJ, Budoff MJ, DeFilippis AP, Blankstein R, Rivera JJ, Agatston A, OLeary DH, Lima J, Blumenthal RS, Nasir K. Associations Between C-Reactive Protein, Coronary Artery Calcium, and Cardiovascular Events, and Implications for the JUPITER Population in MESA: A Population-Based Cohort Study. Lancet. 2011;378:684-92.
15. Blaha MJ, Blumenthal RS, Budoff MJ, Nasir K. Understanding the Utility of Zero Coronary Calcium As a Prognostic Test: A Bayesian Approach. Circ Cardiovasc Qual Outcomes. 2011;4:253-6.
16. Ahmed HM, Blaha MJ, Nasir K, Rivera JJ, Blumenthal RS. Effects of Physical Activity on Cardiovascular Disease. Am J Cardiol. 2012;109:288-95.
17. Minder CM, Blaha MJ, Horne A, Michos ED, Kaul S, Blumenthal RS. Evidence-based Use of Statins For Primary Prevention of Cardiovascular Disease. Am J Med. 2012;125:440-6.
18. Michos ED, Blumenthal RS. How Accurate are 3 Risk Prediction Models in US Women? Circulation. 2012;125:1723-6.
19. Blaha MJ, Nasir K, Blumenthal RS. Statin Therapy for Healthy Men Identified as Increased Risk. JAMA. 2012;307:1489-90.
20. Michos ED, Sibley CT, Baer JT, Blaha MJ, Blumenthal RS. Niacin and Statin Combination Therapy for Atherosclerosis Regression and Prevention of Cardiovascular Disease Events: Reconciling the AIM-HIGH Trial with Previous Surrogate Endpoint Trials. J Am Coll Cardiol. 2012;59:2058-64.
Subclinical atherosclerosis as measured by Cardiac CT or carotid ultrasound.
Individuals with a family history of heart disease.
Heart Disease in Women
Cardiac Computed Tomography
Primary and secondary prevention of coronary heart disease.
- Improved strategies for management of cardiovascular risk factors
- Subclinical coronary atherosclerosis as measured by Cardiac CT
- Individuals with a family history of heart disease
- Heart Disease in Women
- Cardiac Computed Tomography
- Primary and secondary prevention of coronary heart disease
- Cardiovascular Risk Assessment
Fellow, American Heart Association
The Johns Hopkins Medical and Surgical Association
International Atherosclerosis Society
Hyperlipidemia, Subclinical Atherosclerosis
- Hyperlipidemia, Subclinical atherosclerosis